
SS Innovation(Sudhir Srivastava Innovations)
Post-IPO Private PlacementUSD 19M
SEC Form D filing: USD 18,621,498 offering, Rule 506(b) exemption, 25 investors, sales commission USD 175,000. This is the largest filed financing since the IPO and the primary incremental funding channel for the company since listing on Nasdaq. Source: SEC EDGAR Form D (CIK 0001676163)
View funding history →- Valuation
- USD 250M
Company Profile
SS Innovation develops minimally invasive surgical robots in India since 2019. Their systems target precise operations in urology and gynecology, aiming to reduce procedure costs and improve healthcare accessibility at the grassroots level through advanced soft-tissue manipulation technologies.
- Founded
- 2019
- Headquarters
- India
- Website
- ssinnovations.com/
Physix Frontier